Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban).

Author: Gibson, C. Michael MS, MD; Chi, Gerald MD; Halaby, Rim MD; Korjian, Serge MD; Daaboul, Yazan MD; Jain, Purva MPH; Arbetter, Douglas MPH; Goldhaber, Samuel Z. MD; Hull, Russel MBBS; Hernandez, Adrian F. MD; Gold, Alex MD; Bandman, Olga MD; Harrington, Robert A. MD; Cohen, Alexander T. MD; On Behalf of the APEX Investigators

Page: 648-655

http://ift.tt/2lDZ1Jb